메뉴 건너뛰기
Annals of Oncology
Volumn 13, Issue 9, 2002, Pages 1329-1330
Dose density and dose intensity: Where does CHOP go from here?
Author keywords

[No Author keywords available]
Indexed keywords

CD20 ANTIGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; GROWTH FACTOR; MONOCLONAL ANTIBODY; MYELOABLATIVE AGENT; PREDNISONE; RITUXIMAB; VINCRISTINE;
EID: 0036740489     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/mdf238     Document Type: Editorial
Times cited : (2)
References (7)
  • 1
    • 0032884291 scopus 로고    scopus 로고
    • Intensified CHOP in non-Hodgkin's lymphoma: What we know and what we need to know
    • Santoro A, Balzaraotti M, Castagna L. Intensified CHOP in non-Hodgkin's lymphoma: what we know and what we need to know. Ann Oncol 1999; 10: 875-876.
    • (1999) Ann. Oncol , vol.10 , pp. 875-876
    • Santoro, A.1    Balzaraotti, M.2    Castagna, L.3
  • 2
    • 0026087583 scopus 로고
    • The role of dose intensity in determining outcome in intermediate-grade non-Hodgkin's lymphoma
    • Meyer RM, Hryniuk WM, Goodyear MD. The role of dose intensity in determining outcome in intermediate-grade non-Hodgkin's lymphoma. J Clin Oncol 1991; 9: 339-347.
    • (1991) J. Clin. Oncol , vol.9 , pp. 339-347
    • Meyer, R.M.1    Hryniuk, W.M.2    Goodyear, M.D.3
  • 3
    • 0034029617 scopus 로고    scopus 로고
    • Dose-dense chemotherapy for breast cancer: The story so far
    • Hudis C. Dose-dense chemotherapy for breast cancer: the story so far. Br J Cancer 2000; 82: 1897-1899.
    • (2000) Br. J. Cancer , vol.82 , pp. 1897-1899
    • Hudis, C.1
  • 4
    • 0028790440 scopus 로고
    • Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma
    • Philip T, Guglielmi C, Hagenbeek A et al. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. N Engl J Med 1995; 333: 1540-1545.
    • (1995) N. Engl. J. Med , vol.333 , pp. 1540-1545
    • Philip, T.1    Guglielmi, C.2    Hagenbeek, A.3
  • 5
    • 0036739093 scopus 로고    scopus 로고
    • Randomized phase II study of biweekly CHOP and dose-escalated CHOP with prophylactic use of lenograstin (glycosylated G-CSF) in aggressive non-Hodgkin's lymphoma: Japan Clinical Oncology Group Study 9505
    • Itoh K, Ohtsu T, Fukuda H et al. Randomized phase II study of biweekly CHOP and dose-escalated CHOP with prophylactic use of lenograstin (glycosylated G-CSF) in aggressive non-Hodgkin's lymphoma: Japan Clinical Oncology Group Study 9505. Ann Oncol 2002; 13: 1347-1355.
    • (2002) Ann. Oncol , vol.13 , pp. 1347-1355
    • Itoh, K.1    Ohtsu, T.2    Fukuda, H.3
  • 6
    • 0036739435 scopus 로고    scopus 로고
    • Intensified CHOP regimen in aggressive lymphomas: Maximal dose intensity and dose density of doxorubicin and cyclophosphamide
    • Balzarotti M, Spina M, Sarina B et al. Intensified CHOP regimen in aggressive lymphomas: maximal dose intensity and dose density of doxorubicin and cyclophosphamide. Ann Oncol 2002; 13: 1341-1346.
    • (2002) Ann. Oncol , vol.13 , pp. 1341-1346
    • Balzarotti, M.1    Spina, M.2    Sarina, B.3
  • 7
    • 0037165261 scopus 로고    scopus 로고
    • CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma
    • Coiffier B, Lepage E, Briere J et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 2002; 346: 235-242.
    • (2002) N. Engl. J. Med , vol.346 , pp. 235-242
    • Coiffier, B.1    Lepage, E.2    Briere, J.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.